1-6 of 6
Diana Rofail
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Psychometric Evaluation of the PNH Symptom Questionnaire (PNH-SQ) Among Patients with Paroxysmal Nocturnal Hemoglobinuria from Three Phase 2 Clinical Trials with Pozelimab Monotherapy or in Combination with Cemdisiran

Chris Hartford, Paolo Eusebi, Richard J. Kelly, Thibaud Alin, Xinyu Yang, Antoine Regnault, Dimittri Delevry, Ching Lum, Diana Rofail
Journal: Blood
Blood (2023) 142 (Supplement 1): 3752.
https://doi.org/10.1182/blood-2023-181667
Published: 2023
Journal Articles

Patient-Reported Outcomes from a Phase 2, Randomized Trial Evaluating the Safety and Efficacy of Pozelimab and Cemdisiran in Patients with Paroxysmal Nocturnal Hemoglobinuria

Chris Hartford, Bradley Dain, Steven Sherman, Yi Zhang, Rodrigo Pavani, Lisa Aurand, Diana Rofail, Richard Kelly
Journal: Blood
Blood (2022) 140 (Supplement 1): 10849–10850.
https://doi.org/10.1182/blood-2022-163510
Published: 2022
Journal Articles

Improved Patient Satisfaction, Adherence and Health-Related Quality of Life with Deferasirox (Exjade®) in β-Thalassemia Patients Previously Receiving Other Iron Chelation Therapies.

John B. Porter, Miranda Athanasiou-Metaxa, Donald K. Bowden, Jacques Troncy, Dany Habr, Gabor Domokos, Bernard Roubert, Diana Rofail, Adam Gater, Jean-François Baladi, M. Domenica Cappellini
Journal: Blood
Blood (2009) 114 (22): 2486.
https://doi.org/10.1182/blood.V114.22.2486.2486
Published: 2009
Journal Articles

Satisfaction and Adherence Significantly Improves in Patients with β-Thalassemia and Myelodysplastic Syndromes Treated with Deferasirox (Exjade ® )

John B Porter, Donald Bowden, Arnold Ganser, Gabor Domokos, Diana Rofail, Jean-François Baladi, Maria Domenica Cappellini
Journal: Blood
Blood (2008) 112 (11): 1306.
https://doi.org/10.1182/blood.V112.11.1306.1306
Published: 2008
Journal Articles

Quality of Life and Satisfaction with Iron Chelation Therapy in Patients with Beta Thalassemia Major: Results from the ITHACA Study.

Lorenzo Giovanni Mantovani, EconD, DSc, Luciana Scalone, PharmD, DSc, Simona Ravera, MSc, Diana Rofail, MSc, Maria Domenica Cappellini, MD, the ITHACA Study Group
Journal: Blood
Blood (2006) 108 (11): 3344.
https://doi.org/10.1182/blood.V108.11.3344.3344
Published: 2006
Journal Articles

Transfusion and Iron Overload in Thalassemia and Sickle Cell Disease: Impact of Infusion Chelation Therapy on Quality of Life.

Linda Abetz, MA, Jean Francois Baladi, MBA, Paula Jones, MSc, Diana Rofail, MSc
Journal: Blood
Blood (2005) 106 (11): 5570.
https://doi.org/10.1182/blood.V106.11.5570.5570
Published: 2005